PDB Short entry for 1UV5 HEADER TRANSFERASE 14-JAN-04 1UV5 TITLE GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3'- TITLE 2 OXIME COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GSK-3 BETA; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PFASTBAC HTA KEYWDS TRANSFERASE, KINASE, INSULIN PATHWAY, WNT SIGNALING PATHWAY, KEYWDS 2 TRANSFERASE SERINE/THREONINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR R.DAJANI,L.H.PEARL,S.M.ROE REVDAT 4 13-DEC-23 1UV5 1 LINK REVDAT 3 29-MAR-17 1UV5 1 SOURCE SEQADV REVDAT 2 24-FEB-09 1UV5 1 VERSN REVDAT 1 29-JAN-04 1UV5 0 JRNL AUTH L.MEIJER,A.-L.SKALTSOUNIS,P.MAGIATIS,P.POLYCHRONOPOULOUS, JRNL AUTH 2 M.KNOCKAERT,M.LEOST,X.P.RYAN,C.A.VONICA,A.BRIVANLOU, JRNL AUTH 3 R.DAJANI,C.CROVACE,C.TARRICONE,A.MUSACCHIO,S.M.ROE, JRNL AUTH 4 L.H.PEARL,P.GREENGARD JRNL TITL GSK-3-SELECTIVE INHIBITORS DERIVED FROM TYRIAN PURPLE JRNL TITL 2 INDURUBINS JRNL REF CHEM.BIOL. V. 10 1255 2003 JRNL REFN ISSN 1074-5521 JRNL PMID 14700633 JRNL DOI 10.1016/J.CHEMBIOL.2003.11.010 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1276631.370 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 24570 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1204 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3803 REMARK 3 BIN R VALUE (WORKING SET) : 0.3210 REMARK 3 BIN FREE R VALUE : 0.3560 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 203 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.025 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2760 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 112 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 73.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 17.00000 REMARK 3 B22 (A**2) : 17.00000 REMARK 3 B33 (A**2) : -34.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.52 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.57 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.020 REMARK 3 BOND ANGLES (DEGREES) : 1.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.350 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.670 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.000 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.160 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.530 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 55.41 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : BRM3_EPE_PO4.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : BRM3_EPE_PO4.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UV5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JAN-04. REMARK 100 THE DEPOSITION ID IS D_1290014384. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-SEP-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9253 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24630 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.28900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1H8F REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 75.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 5.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 99.00850 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 49.16650 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 49.16650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 148.51275 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 49.16650 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 49.16650 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 49.50425 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 49.16650 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 49.16650 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 148.51275 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 49.16650 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 49.16650 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 49.50425 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 99.00850 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 384 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 121 CG CD OE1 OE2 REMARK 470 LYS A 122 CG CD CE NZ REMARK 470 LYS A 123 CG CD CE NZ REMARK 470 LYS A 292 CG CD CE NZ REMARK 470 ARG A 383 CA C O CB CG CD NE REMARK 470 ARG A 383 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N GLY A 259 O HOH A 2082 2.10 REMARK 500 O ARG A 50 O HOH A 2006 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 136 C - N - CA ANGL. DEV. = 11.8 DEGREES REMARK 500 ARG A 141 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 PRO A 212 C - N - CA ANGL. DEV. = 9.1 DEGREES REMARK 500 PRO A 294 C - N - CA ANGL. DEV. = 10.0 DEGREES REMARK 500 PRO A 294 C - N - CD ANGL. DEV. = -13.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 91 -22.31 62.06 REMARK 500 ASP A 105 99.42 -173.98 REMARK 500 CYS A 107 -8.68 -59.29 REMARK 500 ASP A 124 63.47 37.70 REMARK 500 GLU A 125 83.66 -159.55 REMARK 500 ASP A 181 41.19 -149.26 REMARK 500 PRO A 191 -34.38 -37.66 REMARK 500 ASP A 200 81.04 59.35 REMARK 500 CYS A 218 133.89 85.56 REMARK 500 ARG A 220 -65.88 -21.78 REMARK 500 PHE A 257 72.10 -119.59 REMARK 500 THR A 289 113.57 77.34 REMARK 500 LYS A 292 -110.11 -52.16 REMARK 500 PHE A 293 -104.91 97.96 REMARK 500 PRO A 294 138.48 20.65 REMARK 500 GLN A 295 117.47 118.89 REMARK 500 ILE A 296 160.09 92.33 REMARK 500 LYS A 297 150.23 179.04 REMARK 500 ALA A 298 78.10 42.36 REMARK 500 VAL A 348 130.69 -19.71 REMARK 500 ASN A 352 35.39 -94.44 REMARK 500 PRO A 357 -176.24 -62.37 REMARK 500 LEU A 359 -15.80 -142.81 REMARK 500 ASN A 370 63.39 -172.11 REMARK 500 ALA A 382 -40.62 -169.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CO A1386 CO REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A2110 O REMARK 620 2 HOH A2111 O 56.8 REMARK 620 3 HOH A2112 O 72.2 127.3 REMARK 620 N 1 2 REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 7-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 8-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A1384 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1385 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CO A1386 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A1387 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BRW A1383 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GNG RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE 3BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE REMARK 900 RELATED ID: 1H8F RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA. REMARK 900 RELATED ID: 1I09 RELATED DB: PDB REMARK 900 STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 ( GSK3B) REMARK 900 RELATED ID: 1J1B RELATED DB: PDB REMARK 900 BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITHAMPPNP REMARK 900 RELATED ID: 1J1C RELATED DB: PDB REMARK 900 BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITHADP REMARK 900 RELATED ID: 1O6K RELATED DB: PDB REMARK 900 STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3 REMARK 900 PEPTIDE AND AMP-PNP REMARK 900 RELATED ID: 1O6L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN ACTIVATED AKT/ PROTEIN KINASE B (PKB-PIF REMARK 900 CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE REMARK 900 RELATED ID: 1O9U RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE REMARK 900 RELATED ID: 1PYX RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH AMP-PNP REMARK 900 RELATED ID: 1Q3D RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH STAUROSPORINE REMARK 900 RELATED ID: 1Q3W RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE REMARK 900 RELATED ID: 1Q41 RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH INDIRUBIN-3'- MONOXIME REMARK 900 RELATED ID: 1Q4L RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH INHIBITOR I-5 REMARK 999 REMARK 999 SEQUENCE REMARK 999 HIS 350 IN SWISS-PROT SHOULD BE LEU. THIS CONFLICT HAS REMARK 999 BEEN DESCRIBED IN UNIPROT ENTRY P49841 DBREF 1UV5 A 35 384 UNP P49841 GSKG3B_HUMAN 35 384 SEQRES 1 A 350 SER LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN GLY SEQRES 2 A 350 PRO ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR LYS SEQRES 3 A 350 VAL ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN ALA SEQRES 4 A 350 LYS LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS LYS SEQRES 5 A 350 VAL LEU GLN GLY LYS ALA PHE LYS ASN ARG GLU LEU GLN SEQRES 6 A 350 ILE MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG LEU SEQRES 7 A 350 ARG TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP GLU SEQRES 8 A 350 VAL TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU THR SEQRES 9 A 350 VAL TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS GLN SEQRES 10 A 350 THR LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR GLN SEQRES 11 A 350 LEU PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY ILE SEQRES 12 A 350 CYS HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU ASP SEQRES 13 A 350 PRO ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY SER SEQRES 14 A 350 ALA LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER TYR SEQRES 15 A 350 ILE CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE PHE SEQRES 16 A 350 GLY ALA THR ASP TYR THR SER SER ILE ASP VAL TRP SER SEQRES 17 A 350 ALA GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN PRO SEQRES 18 A 350 ILE PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL GLU SEQRES 19 A 350 ILE ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN ILE SEQRES 20 A 350 ARG GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE PRO SEQRES 21 A 350 GLN ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG PRO SEQRES 22 A 350 ARG THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG LEU SEQRES 23 A 350 LEU GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU GLU SEQRES 24 A 350 ALA CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP PRO SEQRES 25 A 350 ASN VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA LEU SEQRES 26 A 350 PHE ASN PHE THR THR GLN GLU LEU SER SER ASN PRO PRO SEQRES 27 A 350 LEU ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE HET BRW A1383 22 HET PO4 A1384 5 HET CL A1385 1 HET CO A1386 1 HET PO4 A1387 5 HETNAM BRW 6-BROMOINDIRUBIN-3'-OXIME HETNAM PO4 PHOSPHATE ION HETNAM CL CHLORIDE ION HETNAM CO COBALT (II) ION HETSYN BRW (3E)-6'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-OXIME FORMUL 2 BRW C16 H10 BR N3 O2 FORMUL 3 PO4 2(O4 P 3-) FORMUL 4 CL CL 1- FORMUL 5 CO CO 2+ FORMUL 7 HOH *112(H2 O) HELIX 1 1 ASN A 95 LEU A 104 1 10 HELIX 2 2 VAL A 139 ALA A 149 1 11 HELIX 3 3 PRO A 154 SER A 174 1 21 HELIX 4 4 LYS A 183 GLN A 185 5 3 HELIX 5 5 SER A 219 ARG A 223 5 5 HELIX 6 6 ALA A 224 PHE A 229 1 6 HELIX 7 7 SER A 236 GLY A 253 1 18 HELIX 8 8 SER A 261 GLY A 274 1 14 HELIX 9 9 THR A 277 ASN A 285 1 9 HELIX 10 10 PRO A 300 VAL A 304 5 5 HELIX 11 11 PRO A 310 LEU A 321 1 12 HELIX 12 12 THR A 324 ARG A 328 5 5 HELIX 13 13 THR A 330 ALA A 336 1 7 HELIX 14 14 HIS A 337 PHE A 339 5 3 HELIX 15 15 PHE A 340 ASP A 345 1 6 HELIX 16 16 THR A 363 SER A 368 1 6 HELIX 17 17 ASN A 370 PRO A 372 5 3 HELIX 18 18 LEU A 373 ILE A 378 1 6 SHEET 1 AA 8 THR A 38 PRO A 44 0 SHEET 2 AA 8 GLN A 52 GLY A 63 -1 O GLN A 52 N ALA A 42 SHEET 3 AA 8 VAL A 69 LEU A 75 -1 O VAL A 70 N ILE A 62 SHEET 4 AA 8 LEU A 81 GLN A 89 -1 O VAL A 82 N ALA A 73 SHEET 5 AA 8 VAL A 126 ASP A 133 -1 O VAL A 126 N GLN A 89 SHEET 6 AA 8 LEU A 112 SER A 119 -1 N ARG A 113 O VAL A 131 SHEET 7 AA 8 THR A 38 PRO A 44 -1 O THR A 43 N PHE A 115 SHEET 8 AA 8 THR A 38 PRO A 44 0 SHEET 1 AB 3 GLU A 137 THR A 138 0 SHEET 2 AB 3 LEU A 187 ASP A 190 -1 O LEU A 189 N GLU A 137 SHEET 3 AB 3 VAL A 195 LEU A 198 -1 O VAL A 195 N ASP A 190 SHEET 1 AC 2 ILE A 177 CYS A 178 0 SHEET 2 AC 2 LYS A 205 GLN A 206 -1 O LYS A 205 N CYS A 178 LINK CO CO A1386 O HOH A2110 1555 1555 2.63 LINK CO CO A1386 O HOH A2111 1555 1555 2.58 LINK CO CO A1386 O HOH A2112 1555 1555 2.45 SITE 1 AC1 8 HIS A 173 SER A 236 SER A 237 PRO A 331 SITE 2 AC1 8 HOH A2105 HOH A2106 HOH A2107 HOH A2108 SITE 1 AC2 2 LEU A 359 PHE A 360 SITE 1 AC3 5 ASP A 264 HOH A2109 HOH A2110 HOH A2111 SITE 2 AC3 5 HOH A2112 SITE 1 AC4 8 ARG A 96 ARG A 180 LYS A 205 ASN A 213 SITE 2 AC4 8 VAL A 214 GLU A 290 PHE A 291 HOH A2087 SITE 1 AC5 10 ILE A 62 ALA A 83 ASP A 133 TYR A 134 SITE 2 AC5 10 VAL A 135 PRO A 136 ARG A 141 LEU A 188 SITE 3 AC5 10 ASP A 200 HOH A2019 CRYST1 98.333 98.333 198.017 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010169 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010169 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005050 0.00000